Terns Pharmaceuticals
TERN
NASDAQ
IPO2021
about TERN
Terns Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapies, primarily in oncology, with a diverse pipeline of medicines aimed at addressing significant unmet medical needs.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $14.05 | $16.27 | $12.77 | $722.84M | 33.96M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.26 | n/a | n/a | 0% | 0% | 0% |